Literature DB >> 22409937

Progressive gait deterioration in adolescents with Dravet syndrome.

Jill M Rodda1, Ingrid E Scheffer, Jacinta M McMahon, Samuel F Berkovic, H Kerr Graham.   

Abstract

OBJECTIVE: To characterize changes in gait by age in patients with Dravet syndrome.
DESIGN: Prospective, cross-sectional study.
SETTING: Tertiary children's hospital. PATIENTS: Twenty-six subjects with Dravet syndrome, aged 2 to 34 years. Twenty-three patients had mutations of the sodium channel α1 subunit gene, SCN1A.
INTERVENTIONS: Assessment via video gait analysis, physical examination of the lower limbs, use of the Functional Mobility Scale, and radiographs of the pelvis and feet. MAIN OUTCOME MEASURES: Classification of the sagittal gait pattern and foot posture, assessment of muscle extensibility and joint range, and rating of functional mobility.
RESULTS: Children aged 0 to 5 years had a normal or near-normal gait, whereas 5 of 10 children aged 6 to 12 years and 8 of 9 children aged 13 years or older had crouch gait. Physical examination showed that with increasing age, passive knee extension (P = .008) and hip extension (P = .003) decreased, external tibial torsion (P = .007) and pes planovalgus (P = .05) increased, and increased hip internal rotation did not show age-related change (P = .27). The Functional Mobility Scale showed universal independent walking over 5 and 50 m; however, adolescents showed wide variation in their ratings over 500 m, indicating mobility ranging from wheelchair use to independent walking (P = .02).
CONCLUSIONS: Children with Dravet syndrome show progressive gait deterioration in the second decade of life, with crouch gait and skeletal malalignment comprising increased femoral neck anteversion, external tibial torsion, and pes valgus. These age-related changes have a significant impact on mobility and independence in the community setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409937     DOI: 10.1001/archneurol.2011.3275

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

1.  Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome.

Authors:  Alfonso Fasano; Felippe Borlot; Anthony E Lang; Danielle M Andrade
Journal:  Neurology       Date:  2014-05-21       Impact factor: 9.910

Review 2.  Current Treatment Strategies and Future Treatment Options for Dravet Syndrome.

Authors:  Julie Ziobro; Krista Eschbach; Joseph E Sullivan; Kelly G Knupp
Journal:  Curr Treat Options Neurol       Date:  2018-10-13       Impact factor: 3.598

Review 3.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

4.  NaV1.1 haploinsufficiency impairs glutamatergic and GABAergic neuron function in the thalamus.

Authors:  Carleigh Studtmann; Marek Ladislav; Mackenzie A Topolski; Mona Safari; Sharon A Swanger
Journal:  Neurobiol Dis       Date:  2022-02-24       Impact factor: 5.996

Review 5.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

6.  Randomized Controlled Trial of Melatonin for Sleep Disturbance in Dravet Syndrome: The DREAMS Study.

Authors:  Kenneth A Myers; Margot J Davey; Michael Ching; Colin Ellis; Bronwyn E Grinton; Annie Roten; Paul A Lightfoot; Ingrid E Scheffer
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

Review 7.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

8.  Progressive Worsening of Gait and Motor Abnormalities in Older Adults With Dravet Syndrome.

Authors:  Arunan Selvarajah; Carolina Gorodetsky; Paula Marques; Quratulain Zulfiqar Ali; Anne T Berg; Alfonso Fasano; Danielle M Andrade
Journal:  Neurology       Date:  2022-04-13       Impact factor: 11.800

9.  Dysarthria and broader motor speech deficits in Dravet syndrome.

Authors:  Samantha J Turner; Amy Brown; Marta Arpone; Vicki Anderson; Angela T Morgan; Ingrid E Scheffer
Journal:  Neurology       Date:  2017-02-01       Impact factor: 9.910

10.  Genetic testing in individuals with cerebral palsy.

Authors:  Halie J May; Jennifer A Fasheun; Jennifer M Bain; Evan H Baugh; Louise E Bier; Anya Revah-Politi; David P Roye; David B Goldstein; Jason B Carmel
Journal:  Dev Med Child Neurol       Date:  2021-06-10       Impact factor: 4.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.